LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

EKF Diagnostics Highlights Assay Kit and POC Analyzer at AACC 2018

By LabMedica International staff writers
Posted on 01 Aug 2018
Print article
Image: The Glycated Albumin (GA) assay kit (Photo courtesy of EKF Diagnostics).
Image: The Glycated Albumin (GA) assay kit (Photo courtesy of EKF Diagnostics).
EKF Diagnostics (Cardiff, UK), a global in vitro diagnostics company, highlighted its new Stanbio Chemistry Glycated Albumin (GA) assay kit and its newly FDA cleared DiaSpect Tm hemoglobin point of care (POC) analyzer at the AACC 2018 Clinical Lab Expo held in Chicago, Illinois, from July 29 to August 2. AACC is the world’s largest exposition for clinical laboratory products and services.

EKF Diagnostics manufactures POC and central laboratory technology, including tests for hemoglobin, HbA1c, glucose, lactate and a range of chemistry reagents. The company’s POC blood analyzers aid the diagnosis of anemia, diabetes and associated conditions, and its products are used by healthcare professionals in blood banks, GP surgeries, diabetes clinics, pharmacies, sports medicine, emergency rooms and laboratories.

At AACC 2018, EKF highlighted the Stanbio GA assay, which has FDA 510(k) clearance for sale in the US. The Stanbio Chemistry GA assay uses an enzymatic method with liquid reagents and does not require preparation. It can be used on compatible open channel clinical chemistry analyzers and expresses results as a ratio of GA to Albumin in mmol/mol from a small amount of blood serum.

EKF also demonstrated the use of its newly FDA 510(k) cleared and CLIA waived DiaSpect Tm hemoglobin analyzer at this year’s AACC. DiaSpect Tm analyzes whole blood from a sampling microcuvette designed to collect a blood sample from any angle without forming air bubbles, thus minimizing the need to repeat the testing procedure. DiaSpect Tm delivers lab quality hemoglobin results in about one second of the microcuvette being placed in the analyzer, making it the world’s fastest hemoglobin analyzer and ideal for efficient patient health checks and anemia screening at the POC. The hand-held and reagent free system is suitable and cleared for use in POC and Certificate of Waiver settings, including physician’s offices, clinics and other non-traditional laboratory locations.

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Real-time PCR System
GentierX3 Series

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The AI predictive model identifies the most potent cancer killing immune cells for use in immunotherapies (Photo courtesy of Shutterstock)

AI Predicts Tumor-Killing Cells with High Accuracy

Cellular immunotherapy involves extracting immune cells from a patient's tumor, potentially enhancing their cancer-fighting capabilities through engineering, and then expanding and reintroducing them into the body.... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more